Cargando…
Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry
Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792603/ https://www.ncbi.nlm.nih.gov/pubmed/26510907 |
_version_ | 1782421273313280000 |
---|---|
author | Xiao, Wen-jun Zhu, Yao Dai, Bo Zhang, Hai-liang Shi, Guo-hai Shen, Yi-jun Zhu, Yi-ping Ye, Ding-wei |
author_facet | Xiao, Wen-jun Zhu, Yao Dai, Bo Zhang, Hai-liang Shi, Guo-hai Shen, Yi-jun Zhu, Yi-ping Ye, Ding-wei |
author_sort | Xiao, Wen-jun |
collection | PubMed |
description | Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of post-surgical duration on conditional survival (CS) among ACC patients. A total of 641 patients with M0 ACC were selected from the Surveillance, Epidemiology, and End Results (SEER) registry (1988–2012). OS for the entire cohort at 1, 2, 3, 4, 5 and 6 years was 81.4%, 66.8%, 56.3%, 50.3%, 47.2% and 44.3%, respectively. CS for an additional year given prior survival for 0, 1, 2, 3, 4 or 5 years was 81.4%, 81.1%, 83.0%, 87.5%, 93.4% and 93.4%, respectively. Age, tumor stage, tumor grade and marital status affected OS and CS. Increases in 1-year CS over time were more pronounced in patients with poorer prognostic factors. With longer follow-up, tumor stage- and grade-dependent differences in CS decreased or even disappeared. CS may provide more meaningful life expectancy predictions for survivors of ACC than conventional survival analysis. |
format | Online Article Text |
id | pubmed-4792603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-47926032016-03-29 Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry Xiao, Wen-jun Zhu, Yao Dai, Bo Zhang, Hai-liang Shi, Guo-hai Shen, Yi-jun Zhu, Yi-ping Ye, Ding-wei Oncotarget Clinical Research Paper Surgical excision is essential for management of the rare and aggressive neoplasm adrenal cortical carcinoma (ACC). Five-year overall survival (OS) after surgery for ACC is dependent on disease stage, but for all stages the risk of death declines with time after surgery. We calculated the effect of post-surgical duration on conditional survival (CS) among ACC patients. A total of 641 patients with M0 ACC were selected from the Surveillance, Epidemiology, and End Results (SEER) registry (1988–2012). OS for the entire cohort at 1, 2, 3, 4, 5 and 6 years was 81.4%, 66.8%, 56.3%, 50.3%, 47.2% and 44.3%, respectively. CS for an additional year given prior survival for 0, 1, 2, 3, 4 or 5 years was 81.4%, 81.1%, 83.0%, 87.5%, 93.4% and 93.4%, respectively. Age, tumor stage, tumor grade and marital status affected OS and CS. Increases in 1-year CS over time were more pronounced in patients with poorer prognostic factors. With longer follow-up, tumor stage- and grade-dependent differences in CS decreased or even disappeared. CS may provide more meaningful life expectancy predictions for survivors of ACC than conventional survival analysis. Impact Journals LLC 2015-10-14 /pmc/articles/PMC4792603/ /pubmed/26510907 Text en Copyright: © 2015 Xiao et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Clinical Research Paper Xiao, Wen-jun Zhu, Yao Dai, Bo Zhang, Hai-liang Shi, Guo-hai Shen, Yi-jun Zhu, Yi-ping Ye, Ding-wei Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title | Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title_full | Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title_fullStr | Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title_full_unstemmed | Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title_short | Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
title_sort | conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry |
topic | Clinical Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792603/ https://www.ncbi.nlm.nih.gov/pubmed/26510907 |
work_keys_str_mv | AT xiaowenjun conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT zhuyao conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT daibo conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT zhanghailiang conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT shiguohai conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT shenyijun conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT zhuyiping conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry AT yedingwei conditionalsurvivalamongpatientswithadrenalcorticalcarcinomadeterminedusinganationalpopulationbasedsurveillanceepidemiologyandendresultsregistry |